Bergamot and Statins: Can You Take Them Together?

Moderate — Timing Mattersfood
Evidence-gradedLast reviewed June 1, 2026Source: Zhang et al., Pharmacokinetics and pharmacodynamic interaction of bergamottin with atorvastatin in rats (Xenobiotica, 2022)
Learn about each ingredient:BergamotStatins

Quick answer

Bergamot orange (Citrus bergamia) is the source of bergamottin, the prototype furanocoumarin that inactivates CYP3A4. Bergamot juice and concentrated bergamot polyphenol supplements (often marketed for cholesterol) could in theory raise levels of CYP3A4-metabolized statins (simvastatin, atorvastatin, lovastatin). The mechanism is well established in the lab and in animals, but no direct human pharmacokinetic studies of bergamot with statins exist, so the real-world magnitude is uncertain.

If you take a CYP3A4-metabolized statin (simvastatin, atorvastatin, lovastatin), be cautious with concentrated bergamot products such as bergamot polyphenol supplements, bergamot juice, or bergamot oil taken internally, since bergamottin can inhibit CYP3A4 and may raise statin levels. Occasional Earl Grey tea is unlikely to matter. Pravastatin, rosuvastatin, and fluvastatin do not depend on CYP3A4. Review combining any bergamot supplement with a statin with your doctor or pharmacist.

What happens?

Bergamot is the original source of bergamottin, the same furanocoumarin behind the grapefruit-statin warning. Concentrated bergamot products can inhibit the enzyme that clears certain statins, potentially raising their levels in the blood.

1

Bergamottin exposure

Concentrated bergamot, polyphenol supplements, juice, or oil taken internally, delivers bergamottin and related furanocoumarins to the lining of the small intestine.

2

CYP3A4 inactivation

Bergamottin binds to and irreversibly inactivates CYP3A4, the enzyme that normally breaks down simvastatin, atorvastatin, and lovastatin before they reach the bloodstream.

3

Higher statin levels

With less enzyme working, more statin survives first-pass absorption and plasma levels climb above what the prescribed dose would normally produce, raising the risk of muscle injury.

The concern applies only to the <strong>CYP3A4-dependent statins</strong> (simvastatin, atorvastatin, lovastatin); pravastatin, rosuvastatin, and fluvastatin use other pathways and are not expected to interact.

Why is this important?

This interaction matters less for its raw strength and more for who is exposed to it. Bergamot polyphenol supplements are marketed to people with high cholesterol, the very same population already taking statins.

Overlapping population

Many people combine a bergamot cholesterol supplement with a statin without realizing bergamot belongs to the same furanocoumarin family that triggers grapefruit warnings on statin labels.

Muscle injury risk

Higher statin levels raise the risk of the dose-related side effect that matters most: muscle injury (myopathy, and rarely rhabdomyolysis).

Dose and frequency

The effect depends on how much and how often. A daily concentrated polyphenol supplement is a large, sustained exposure, whereas an occasional cup of Earl Grey tea delivers only a trace.

Because the strongest evidence is mechanistic and from animals rather than humans, this is best treated as a plausible, moderate-level caution rather than a proven, dramatic interaction.

Which specific products are affected?

Many common Statins products can affect this interaction.

CYP3A4-dependent statins affected

Simvastatin (Zocor)Atorvastatin (Lipitor)Lovastatin (Mevacor)

Concentrated bergamot products to be cautious with

Bergamot polyphenol supplements (BPF, e.g. Bergamonte)Bergamot juice or concentrateBergamot essential oil taken internallyVery heavy daily Earl Grey tea consumption

Other sources

  • •Other CYP3A4-dependent cardiovascular drugs (felodipine, amlodipine, amiodarone)
  • •Immunosuppressants (cyclosporine, tacrolimus, sirolimus)

Not affected: pravastatin, rosuvastatin, and fluvastatin are cleared by other pathways and are not expected to interact. Bergamot in cosmetics and aromatherapy is also not relevant, the issue is internal exposure.

The bottom line

Bergamot is the original source of bergamottin, the furanocoumarin behind the grapefruit-statin interaction, so concentrated bergamot products can in theory raise levels of CYP3A4-dependent statins (simvastatin, atorvastatin, lovastatin). The mechanism is well established in the lab and supported by animal data, but no direct human studies exist, so the real-world magnitude is uncertain. An occasional cup of Earl Grey tea is unlikely to matter; concentrated bergamot polyphenol supplements and juice are the real exposures to be cautious about.

If you want to combine a bergamot supplement with your statin, talk to your doctor or pharmacist, and watch for muscle pain, weakness, or dark urine.

What happens when you take bergamot with statins?

Bergamot (Citrus bergamia) is a sour citrus fruit grown almost exclusively in Calabria, Italy. It is the source of bergamot essential oil, which gives Earl Grey tea its characteristic aroma, and of bergamot polyphenol supplements, concentrated extracts marketed for cardiovascular health and cholesterol management. Bergamot is also the namesake of bergamottin, the furanocoumarin first identified as a major CYP3A4 inhibitor in grapefruit juice.

Here is the chain of events the chemistry predicts:

  1. Concentrated bergamot delivers bergamottin and related furanocoumarins to the lining of the small intestine.
  2. These compounds bind to and inactivate CYP3A4, the enzyme that normally breaks down a large fraction of certain statins before they ever reach the bloodstream.
  3. With less enzyme working, more statin survives first-pass absorption.
  4. Plasma statin concentrations climb above what the prescribed dose would normally produce.
  5. Higher statin levels raise the risk of the dose-related side effect that matters most: muscle injury (myopathy, and rarely rhabdomyolysis).

The statins that depend on CYP3A4 are simvastatin, atorvastatin, and lovastatin. Laboratory studies confirm that bergamottin inactivates CYP3A4, and an animal study found that bergamottin raised atorvastatin exposure. What does not exist is a direct human study of a bergamot supplement taken with a statin, so the mechanism is solid but the precise size of the effect in people is unknown.

Why is this important?

This interaction matters less because of how strong it is and more because of who is exposed to it. Bergamot polyphenol supplements are promoted to people with elevated cholesterol, which is the same population already taking statins. Many users combine the two without realizing bergamot belongs to the same furanocoumarin family that triggers grapefruit warnings on statin labels.

The building blocks of the concern are well established:

  • Bergamottin inactivates CYP3A4 in the lab, which is the same mechanism behind the grapefruit-statin interaction.
  • Bergamot juice and oil contain bergamottin and related furanocoumarins.
  • In animals, bergamottin raised atorvastatin exposure, consistent with the proposed mechanism.

The effect is expected to depend on how much bergamot you take and how often. A cup of Earl Grey tea delivers only a trace of bergamot oil and is unlikely to meaningfully affect the enzyme in most people. A daily concentrated polyphenol supplement is a far larger and more sustained exposure. Heavy daily tea drinkers sit somewhere in between.

Because the strongest evidence is mechanistic and from animals rather than humans, this is best treated as a plausible, moderate-level caution rather than a proven, dramatic interaction. The sensible posture is to avoid stacking a concentrated bergamot product on top of a CYP3A4 statin without medical input, not to panic over a teacup.

What should you do?

The goal is simple: keep concentrated bergamot away from a CYP3A4-dependent statin unless your prescriber has signed off, and watch for muscle symptoms.

Before changing anything:

  • Check which statin you take. Simvastatin, atorvastatin, and lovastatin go through CYP3A4 and are the ones relevant here. Pravastatin, rosuvastatin, and fluvastatin do not.
  • If you are considering a bergamot polyphenol supplement for cholesterol while already on a statin, raise it with your prescriber first rather than starting on your own.

Every day, while taking a CYP3A4 statin:

  • Skip concentrated bergamot products: polyphenol supplements, bergamot juice or concentrate, and bergamot essential oil taken internally (which is not advisable in general).
  • An occasional cup of Earl Grey tea is unlikely to be a problem. If you drink it heavily every day, mention it to your pharmacist.
  • Take your statin as prescribed; do not change your dose on your own.

After any change (starting bergamot, or being switched):

  • Watch for muscle pain, weakness, dark urine, or unusual fatigue, and report these promptly. They are warning signs of statin-related muscle injury whatever the cause.
  • If your prescriber approves combining a bergamot supplement with your statin, follow whatever monitoring they recommend.
  • If bergamot supplements matter to you, ask whether switching to pravastatin, rosuvastatin, or fluvastatin makes sense, since those are not affected.

Which specific products are affected?

This caution applies to the statins metabolized via CYP3A4: simvastatin (Zocor), atorvastatin (Lipitor), and lovastatin (Mevacor). Other CYP3A4-dependent cardiovascular drugs (such as felodipine, amlodipine, and amiodarone) and immunosuppressants (cyclosporine, tacrolimus, sirolimus) may also interact with concentrated bergamot products through the same mechanism.

On the bergamot side, the products of concern are concentrated polyphenol supplements (often labeled bergamot extract or BPF, sold under brand names such as Bergamonte), bergamot juice or concentrate, bergamot essential oil taken internally, and very heavy daily Earl Grey tea consumption. Bergamot in cosmetics and aromatherapy is not relevant; the issue is internal exposure.

Not affected: pravastatin, rosuvastatin, and fluvastatin are cleared by other pathways and are not expected to interact with bergamot.

The science behind it

The link to statins specifically comes from animal work: Zhang and colleagues reported that bergamottin altered the pharmacokinetics of atorvastatin in rats, raising its exposure (Zhang X, et al. Xenobiotica. 2022;52(5):463-467; PMID 35699169). This is an animal pharmacokinetic study in rats, not a human trial.

The mechanistic foundation is well documented. He and colleagues showed that bergamottin is a mechanism-based (irreversible) inactivator of CYP3A4 in vitro, identifying it as a key component behind the grapefruit-drug interaction (He K, et al. Chem Res Toxicol. 1998;11(4):252-259; PMID 9548795). This is an in vitro mechanistic study.

What is missing is the most important piece for clinical certainty: a direct human pharmacokinetic study of a bergamot product taken with a statin. Until that exists, the interaction should be read as mechanistically plausible and supported by animal data, not as a quantified human effect. That is why this sits at a moderate, precautionary level rather than a strong warning.

Frequently Asked Questions

Is drinking Earl Grey tea dangerous on a statin?

An occasional cup is very unlikely to cause a problem, because it delivers only a trace of bergamot oil. If you drink Earl Grey heavily every day and take simvastatin or lovastatin, it is worth mentioning to your pharmacist.

Can I take a bergamot cholesterol supplement together with my statin?

Not without checking first. Bergamot polyphenol supplements are a concentrated, sustained exposure to the furanocoumarins that can inhibit CYP3A4. If you want to combine the two, discuss it with your prescriber so the combination can be supervised.

Does this affect every statin?

No. Only the CYP3A4-dependent statins (simvastatin, atorvastatin, lovastatin) are relevant. Pravastatin, rosuvastatin, and fluvastatin use other pathways and are not expected to interact with bergamot.

Is this the same as the grapefruit-statin warning?

It shares the same mechanism. Bergamottin, the compound at the center of the grapefruit interaction, is named after and found in bergamot. The difference is that grapefruit's effect on statins has been measured in humans, whereas bergamot's has not.

How strong is the evidence that bergamot raises statin levels?

The mechanism is well established in the lab, and one animal study supports it for atorvastatin. There are no direct human studies, so the real-world size of the effect is uncertain. That is why the advice is cautious rather than absolute.

What symptoms should make me call my doctor?

Muscle pain, weakness, dark urine, or unusual fatigue. These can signal statin-related muscle injury and should be reported promptly, regardless of whether you are using bergamot.

Key takeaways

  • Bergamot is the original source of bergamottin, the furanocoumarin behind the grapefruit-statin interaction.
  • The concern applies to CYP3A4-dependent statins: simvastatin, atorvastatin, and lovastatin.
  • The mechanism is established in the lab and supported by animal data, but there are no direct human studies, so the magnitude in people is uncertain.
  • Occasional Earl Grey tea is unlikely to matter; concentrated bergamot polyphenol supplements and bergamot juice are the real exposures to be cautious about.
  • Pravastatin, rosuvastatin, and fluvastatin are not CYP3A4-dependent and are not expected to interact.
  • If you want to combine bergamot with a statin, talk to your doctor or pharmacist, and watch for muscle pain, weakness, or dark urine.

Other Statins interactions

See all →
+ pomegranatemoderate+ oat fibermoderate+ alcoholmoderate

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Zhang et al., Pharmacokinetics and pharmacodynamic interaction of bergamottin with atorvastatin in rats (Xenobiotica, 2022) ↗

Reviewed June 1, 2026. How we grade evidence →

Related Topics

bergamotbergamottinstatinssimvastatinatorvastatincyp3a4furanocoumarinearl greybergamot polyphenol

Related Interactions

Other interactions you should know about

Seville Orange + Red Yeast Rice

high

Seville orange contains furanocoumarins that inhibit intestinal CYP3A4, the enzyme that clears the monacolin K in red yeast rice. Because monacolin K is chemically identical to the statin lovastatin and depends on CYP3A4 for its first-pass breakdown, blocking that enzyme raises systemic exposure to the active statin, increasing the risk of muscle-related side effects such as myopathy and, rarely, rhabdomyolysis.

Pomelo + Red Yeast Rice

high

Pomelo, like grapefruit, contains furanocoumarins that inhibit the intestinal CYP3A4 enzyme. Red yeast rice's active constituent, monacolin K, is chemically identical to the statin lovastatin, which depends on CYP3A4 for its breakdown. When pomelo blocks that enzyme, more of the monacolin K reaches the bloodstream, amplifying the dose-dependent statin-type risks of muscle injury and, rarely, liver enzyme elevation. Because furanocoumarin inhibition can persist for days, the effect is not reliably avoided by taking the two at different times of day.

St. John's Wort + Red Yeast Rice

moderate

St. John's wort is a strong inducer of the CYP3A4 enzyme system that clears the statin-like compound (monacolin K, chemically identical to lovastatin) in red yeast rice. Taking them together speeds up how the body breaks down that compound, lowering its levels and weakening red yeast rice's cholesterol-lowering effect. The concern here is loss of benefit rather than toxicity, and the direction is the opposite of CYP3A4-inhibitor interactions, so it does not raise muscle-injury risk.

Clarithromycin + Red Yeast Rice

high

Clarithromycin is a strong CYP3A4 inhibitor. Red yeast rice's active compound, monacolin K, is chemically identical to the statin lovastatin and is cleared mainly by CYP3A4. Combining them slows clearance of the statin-like compound and raises its blood levels, increasing the risk of muscle injury and, rarely, rhabdomyolysis.

Grapefruit + Red Yeast Rice

high

Grapefruit inhibits intestinal CYP3A4, the enzyme that clears red yeast rice's active constituent monacolin K (the same molecule as the statin lovastatin). Blocking this enzyme lets more monacolin K reach the bloodstream, raising its cholesterol-enzyme-blocking activity and the associated risk of muscle-related side effects. This is a food-drug interaction driven by the grapefruit inhibitor, and because some unregulated red yeast rice products carry near-prescription statin content, the risk can be meaningful.

Digoxin + St. John's Wort

high

St. John's wort revs up a gut transporter that digoxin depends on for absorption, so combining them quietly drains digoxin from the bloodstream. Because digoxin has so little room to spare, that drop can leave the drug too weak to control your heart.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free